EXAS stock

EXACT Sciences Corporation (EXAS) earnings · rev $3.25B

These earnings events as JSON? API free 100/day

EXACT Sciences Corporation (EXAS) is a diagnostics & research company listed on NASDAQ.

This EXAS earnings page is the cached print — revenue, income, and the latest exhibit — not a live call transcript.

Latest reported EXAS revenue for 2025-12-31 was $3.25B. Net income was -$207.9M. Revenue was up 55.8% from 2022-12-31 to 2025-12-31. EXAS currently screens at market cap $20.03B.

When the next EXAS 8-K Item 2.02 lands, this page should move. Until then the SEC archive is the source.

The change that matters: Revenue was up 55.8% from 2022-12-31 to 2025-12-31. An earnings headline that ignores that move is noise.

Not investment advice. Full EXAS research stays on the stock page; the tape stays on the quote page.

EXAS earnings FAQ

What are EXAS's latest revenue and net income?

Latest cached EXACT Sciences Corporation (EXAS) revenue for Dec 31, 2025 was $3.25B. Net income was -$207.9M. Statements: https://lician.com/financials/exas

What is EXAS's latest diluted EPS?

Latest cached EXACT Sciences Corporation (EXAS) diluted EPS for Dec 31, 2025 was -$1.10.

What period does the latest EXAS earnings print cover?

The latest cached EXACT Sciences Corporation (EXAS) earnings print covers Dec 31, 2025. The prior cached period on this page is Dec 31, 2022.

How did EXAS revenue change from the prior cached period?

Cached EXACT Sciences Corporation (EXAS) revenue was up 55.8% from $2.08B (Dec 31, 2022) to $3.25B (Dec 31, 2025). Statements: https://lician.com/financials/exas

Where are EXAS earnings listed?

Cached earnings facts for EXACT Sciences Corporation (EXAS) are listed at https://lician.com/earnings/exas. Statements: https://lician.com/financials/exas

Not investment advice.

Full EXAS analysis